Fagan Associates’s Express Scripts Holding Company ESRX Stock Holding History

Fagan Associates’s Portfolio ESRX Stock Details ESRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-25,948	Closed	-$2.27M	–	97
2015 Q4	$2.27M	Buy	25,948 +3,055	+13%	+$262K	1.51%	20
2015 Q3	$1.85M	Sell	22,893 -2,645	-10%	-$230K	1.36%	24
2015 Q2	$2.27M	Buy	25,538 +3,900	+18%	+$341K	1.52%	22
2015 Q1	$1.88M	Sell	21,638 -12,630	-37%	-$1.06M	1.39%	26
2014 Q4	$2.9M	Buy	34,268 +1,020	+3%	+$79.7K	2.31%	12
2014 Q3	$2.35M	Buy	33,248 +155	+0.5%	+$11K	1.93%	14
2014 Q2	$2.29M	Buy	33,093 +2,575	+8%	+$181K	1.96%	15
2014 Q1	$2.29M	Buy	+30,518	New	+$2.29M	1.98%	16

Other funds holding ESRX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Fagan Associates's ESRX Position: Q1 2016 in Review

Fagan Associates sold out of Express Scripts Holding Company (ESRX) in Q1 2016, closing a stake of 25,948 shares — an estimated $2.27M sold.

Fagan Associates first reported a position in ESRX in Q1 2014 and held it in 8 quarters. The position peaked at $2.9M in Q4 2014. 1,221 funds tracked by Wall St. Rank hold ESRX as of Q1 2016.

Fagan Associates reported no remaining Express Scripts Holding Company position as of Q1 2016 after selling out during the quarter.
Fagan Associates sold 25,948 Express Scripts Holding Company shares in Q1 2016, an estimated $2.27M.
Fagan Associates first reported a position in Express Scripts Holding Company in Q1 2014 and held it in 8 quarters.
Fagan Associates's Express Scripts Holding Company position peaked at $2.9M in Q4 2014.
1,221 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q1 2016.

Based on Fagan Associates's 13F filing for Q1 2016, filed 13 May 2016.